A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61K 9/00 (2006.01) A61K 45/08 (2006.01) A61P 15/10 (2006.01)
Patent
CA 2394060
A method is provided for treating erectile dysfunction in a mammalian male individual. The method involves the transmucosal administration of a phosphodiesterase inhibitor or a pharmaceutically acceptable salt, ester, amide or derivative thereof, within the context of an effective dosing regimen. Preferred modes of administration include transbuccal, sublingual and transrectal routes. Pharmaceutical formulations and kits are provided as well.
L'invention concerne une méthode de traitement de la dysérection chez un individu mâle mammalien. Ladite méthode comprend l'administration à travers les muqueuses d'un inhibiteur de phosphodiestérase ou d'un sel acceptable pharmaceutiquement, d'un ester, d'un amide ou d'un dérivé correspondant, dans le contexte d'un régime à dosage efficace. Des modes préférés d'administration comprennent les voies buccales, sublinguales et transrectales. Cette invention concerne également des préparations pharmaceutiques et des kits.
Doherty Paul C. Jr.
Place Virgil A.
Smith William L.
Battison Williams Dupuis
Vivus Inc.
LandOfFree
Transmucosal administration of phosphodiesterase inhibitor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transmucosal administration of phosphodiesterase inhibitor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transmucosal administration of phosphodiesterase inhibitor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1846959